Enantiomeric synthesis of carbocyclic analogs of D- and L-6-azapyrimidine ribonucleosides

Canadian Journal of Chemistry

Volumn 84, Issue 4, 2006, Pages 748-754

  Liu, Peng ^a   Chu, Chung K ^a  

^a UNIVERSITY OF GEORGIA   (United States)

Author keywords

6 azapyrimidine nucleosides; Carbocyclic nucleosides; Enantiomeric synthesis

Indexed keywords

AROMATIC COMPOUNDS; GLUCOSE; SYNTHESIS (CHEMICAL);

6-AZAPYRIMIDINE NUCLEOSIDES; CARBOCYCLIC NUCLEOSIDES; ENANTIOMERIC SYNTHESIS;

NITROGEN COMPOUNDS;

1 [2,3 DIHYDROXY 4 (HYDROXYMETHYL)CYCLOPENT 1 YL] 6 AZACYTOSINE HYDROCHLORIDE; 1 [2,3 DIHYDROXY 4 (HYDROXYMETHYL)CYCLOPENT 1 YL] 6 AZATHYMINE; 1 [2,3 DIHYDROXY 4 (HYDROXYMETHYL)CYCLOPENT 1 YL] 6 AZAURACIL; AZAURIDINE; DEXTRO 6 AZAPYRIMIDINE RIBONUCLEOSIDE DERIVATIVE; LEVO 2,3 O CYCLOHEXYLIDENE 4 CYCLOPENTENONE; LEVO 6 AZAPYRIMIDINE RIBONUCLEOSIDE DERIVATIVE; LEVO CYCLOPENTYL 6 AZAPYRIMIDINE NUCLEOSIDE DERIVATIVE; RIBONUCLEOSIDE DERIVATIVE; THIOL GROUP; UNCLASSIFIED DRUG;

ARTICLE; ENANTIOMER; METHODOLOGY; SYNTHESIS;

EID: 33745913323     PISSN: 00084042     EISSN: None     Source Type: Journal    
DOI: 10.1139/V06-052     Document Type: Article

References (30)

1. D. Voet and J.G. Voet. Biochemistry. 2nd ed. John Wiley and Sons, New York. 1995.
2. G. Gumina, Y. Chong, H. Choo, G. Song, and C.K. Chu. Curr. Top. Med. Chem. 2, 1065 (2002).
3. D.C. Orr, H.T. Figueiredo, C.L. Mo, C.R. Penn, and J.M. Cameron. J. Bio. Chem. 267, 4177 (1992).
4. (a) M.A. Turner, X. Yang, D. Yin, K. Kuczera, R.T. Borchardt, and P.L. Howell. Cell Biochem. Biophys. 33, 101 (2000);
5. (b) Y. Kitade, C. Kozaki, T. Miwa, and M. Nakanishi. Tetrahedron, 58, 1271 (2002)
6. (a) K.S. Anderson. Biochim. Biophys. Acta, 1587, 296 (2002);
7. (b) G. Maga and S. Spadari. Curr. Drug Metab. 3, 73 (2002).
8. (a) M.J. Otto. Curr. Opin. Pharm. 4, 431 (2004);
9. (b) P.J. Ruane and E. DeJesus. J. Acquired Immune Defic. Syndr. 37, S21 (2004).
10. R. Fleischer, D. Boxwell, and K.E. Sherman. Clin. Infect. Dis. 38, 79 (2004).
11. X. Tan, C.K. Chu, and F.D. Boudinot. Adv. Drug Delivery Rev. 39, 117 (1999).
12. T. Shirasaka, M.F. Kavlick, T. Ueno, W.Y. Gao, E. Kojima, M.L. Alcaide, S. Chokekijchai, B.M. Roy, E. Arnald, R. Yarchoan, and H. Mitsuya. Proc. Natl. Acad. Sci. U.S.A. 92, 2398 (1995).
13. M.T. Crimmins. Tetrahedron, 54, 9229 (1998).
14. R.J. Ferrier. Carbohydr. Chem. 34, 248 (2003).
15. S.M. Douglas, S.S. Good, M.B. Faletto, W.H. Miller, M.H. St Clair, L.R. Boone, M. Tisdale, N.R. Parry, J.E. Reardon, R.E. Dornsife, D.R. Averett, and T.A. Krenitsky. Antimicrob. Agents Chemother. 41, 1082 (1997).
16. S. Levine, D. Hernandez, G. Yamanaka, S. Zhang, R. Rose, S. Weinheimer, and R.J. Colonno. Antimicrob. Agents Chemother. 46, 2525 (2002).
17. S.P. Samijlenko, I.V. Alexeeva, L.H. Palchykivs'ka, I.V. Kondratyuk, A.V. Stepanyuin, A.S. Shalamay, and D.M. Hovorun. J. Mol. Struct. 484, 31 (1999).
18. L.L. Wotring and L.B. Townsend. Cancer Res. 49, 289 (1989).
19. J.D. Morrey, D.F. Smee, R.W. Sidwell, and C. Tseng. Antiviral Res. 55, 107 (2002).
20. Y.H. Jin, P. Liu, J. Wang, R. Baker, J. Huggins, and C.K. Chu. J. Org. Chem. 68, 9012 (2003).
21. W.W. Zorbach and R.S. Tipson. Synthetic procedures in nucleic acid chemistry. John Wiley and Sons, New York. 1973. p. 102.
22. C.C. Tzeng, N.C. Motola, and R.P. Panzica. J. Org. Chem. 48, 1271 (1983).
23. J. Daunis and M. Follet. J. Heterocycl. Chem. 14, 729 (1977).
24. (a) C. Cristescu. Rev. Roum. Chim. 31, 881 (1986);
25. (b) C. Cristescu and S. Tomas. Rev. Roum. Chim. 34, 1321 (1989).
26. H.R. Moon, W.J. Choi, H.O. Kim, and L.S. Jeong. Tetrahedron: Asymmetry, 13, 1189 (2002).
27. T.V. RajanBabu, W.A. Nugent, D.F. Taber, and P.J. Fagan. J. Am. Chem. Soc. 110, 7128 (1988).
28. K. Mori and H. Kikuchi. Liebigs Ann. Chem. 1267 (1989).
29. B. Sundermann and H. Scharf. Tetrahedron: Asymmetry, 7, 1995 (1996).
30. M.S. Wolfe, B.L. Anderson, D.R. Borcherding, and R.T. Borchardt. J. Org. Chem. 55, 4712 (1990).